Cargando…
Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
Liver transplantation (LT) is the treatment of choice for patients with cirrhosis, decompensated disease, acute liver failure, and hepatocellular carcinoma (HCC). In 3–25% of cases, an alarming problem is acute and chronic cellular rejection after LT, and this event can lead to the need for new tran...
Autores principales: | Abenavoli, Ludovico, Scarlata, Giuseppe Guido Maria, Paravati, Maria Rosaria, Boccuto, Luigi, Luzza, Francesco, Scarpellini, Emidio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376769/ https://www.ncbi.nlm.nih.gov/pubmed/37509432 http://dx.doi.org/10.3390/biomedicines11071792 |
Ejemplares similares
-
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition
por: Abenavoli, Ludovico, et al.
Publicado: (2023) -
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023) -
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
por: Abenavoli, Ludovico, et al.
Publicado: (2023) -
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
por: Abenavoli, Ludovico, et al.
Publicado: (2022) -
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series
por: Abenavoli, Ludovico, et al.
Publicado: (2023)